Published on in Vol 26 (2024)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/65440, first published
.
Journals
- Turnock L, Hearne E, Lazuras L. Made in China: The international supply of illicit Semaglutide and weight-loss medicines online. Emerging Trends in Drugs, Addictions, and Health 2025;5:100169 View
- O'Keefe J, Franco W, O'Keefe E. Anti-consumption agents: Tirzepatide and semaglutide for treating obesity-related diseases and addictions, and improving life expectancy. Progress in Cardiovascular Diseases 2024 View
- Basdevant A. Inhibiteurs de l’appétit et prévention de l’obésité. Médecine des Maladies Métaboliques 2025 View
- Miot H. Commentary on “Facial Remodeling Addressing Fat Loss and Skin Sagging With Poly-l-Lactic Acid SCA and Hyaluronic Acid Filler After Semaglutide-Associated Prescriptive Weight Loss”. Dermatologic Surgery 2025 View